Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-16
1997-04-22
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514341, 514397, 5462751, 5483151, 5483381, A61K 31415, C07D40112, C07D40912, C07D23361
Patent
active
056229828
ABSTRACT:
The invention concerns azole compounds of formula ##STR1## wherein the substituents have various significances, in free form or salt form.
They can be prepared e.g. by acylation, or by aziridine or oxazole ring opening.
The compounds can be used as pharmaceuticals, especially as selective inhibitors of the 25-hydroxyvitamin D3--hydroxylases in the treatment of disorders of proliferation and differentiation in vitamin D--responsive tissues.
REFERENCES:
patent: 3796704 (1974-03-01), Metzger et al.
patent: 4191767 (1980-03-01), Warner, Jr. et al.
European Patient Office Patent Abstracts JP4005287 --Sep. 1, 1992 --Page 1 of 1.
Chem. Abstract 108:21901 vol. 108, 1988 --2 pages.
Egger Helmut
Schuster Ingeborg
Honor Robert S.
Kassenoff Melvyn M.
McGovern Thomas O.
Morris Patricia L.
Sandoz Ltd.
LandOfFree
Acylated aminoalkanimidazoles and - triazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated aminoalkanimidazoles and - triazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated aminoalkanimidazoles and - triazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342086